McKesson Presents Innovative Solutions at ASHP Midyear Clinical Meeting
Summary
Andy Wilson, PharmD, FASHP, vice president of 340B Solutions at McKesson, will participate in several book signings and ‘meet the author’ events promoting his 340B Program Handbook .McKesson RxO ® will highlight improved financial and operational outcomes through its evidence-based programs, products and services including pharmacy revenue cycle analysis and indigent drug recovery solutions.Macro Helix , a McKesson company, will feature solutions to help covered entities maximize 340B program participation with industry-leading software and services that target the operational, financial and regulatory complexities to maintain compliance, ensure reimbursement and help health systems improve patient access to affordable healthcare.PipelineRx ® , a McKesson Ventures-backed portfolio company, will highlight its expanded strategy to achieve integrated medication management across care settings.United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients.
Classifications
AskAI Classifications
LabelsLinked Companies
